Gene: KIF3C
Official Full Name: kinesin family member 3Cprovided by HGNC
Gene Summary: Predicted to enable ATP hydrolysis activity; microtubule binding activity; and microtubule motor activity. Predicted to be involved in microtubule-based movement. Predicted to be located in microtubule cytoskeleton; neuronal cell body; and neuronal ribonucleoprotein granule. Predicted to be part of kinesin complex. Predicted to be active in cytoplasm and microtubule. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO36966 | KIF3C Knockout cell line (HeLa) | Human | KIF3C | 1:3~1:6 | Negative | Online Inquiry |
KO36967 | KIF3C Knockout cell line (HCT 116) | Human | KIF3C | 1:2~1:4 | Negative | Online Inquiry |
KO36968 | KIF3C Knockout cell line (HEK293) | Human | KIF3C | 1:3~1:6 | Negative | Online Inquiry |
KO36969 | KIF3C Knockout cell line (A549) | Human | KIF3C | 1:3~1:4 | Negative | Online Inquiry |
KIF3C Gene Knockout Cell Lines are advanced biological tools designed to facilitate the study of the KIF3C gene, which encodes a critical motor protein involved in intracellular transport mechanisms. These cell lines are genetically engineered to have the KIF3C gene disrupted, allowing researchers to investigate the various physiological roles mediated by this protein, particularly in the context of cellular trafficking, organelle positioning, and mitotic functions.
The functionality of KIF3C is rooted in its motor activity on microtubules, where it plays a pivotal role in vesicular transport and the movement of cellular components. By using KIF3C Gene Knockout Cell Lines, scientists can effectively explore the consequences of the gene loss on cellular behavior, signaling pathways, and overall cellular homeostasis. This model is especially valuable in cancer research, neurobiology, and studies of developmental biology, where understanding the intricacies of intracellular transport can yield critical insights into disease mechanisms.
One of the significant advantages of KIF3C Gene Knockout Cell Lines is their precision and reliability in gene editing, offering a robust alternative to traditional gene silencing approaches like RNA interference, which may not achieve complete knockdown. Unlike other existing models, the knockout technology ensures consistent loss of function across subcultures, providing more reproducible experimental outcomes. This specificity is essential in elucidating the precise role of KIF3C in various biological contexts, making it an indispensable tool for researchers aiming for clarity in their studies.
In a clinical context, understanding the role of KIF3C could lead to novel therapeutic strategies targeting diseases associated with dysregulated intracellular transport. Researchers and clinicians alike will find these cell lines valuable for translating basic scientific discoveries into potential clinical applications.
Our company's expertise in genetic engineering and validated cell line production guarantees that KIF3C Gene Knockout Cell Lines meet high standards of quality and performance. By choosing our cell lines, you are leveraging cutting-edge technology backed by a commitment to advancing scientific discovery.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.